[Role of daunomycin in the treatment of acute leukemia in children].
D001855:Bone Marrow Diseases / Q000139:chemically induced; D002648:Child; D003630:Daunorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D003907:Dexamethasone; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin
Ruolo della daunomicina nel trattamento della leucemia acuta del bambino.